+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Gene Therapy"

From
From
From
From
Gene Therapy-Competitive landscape, 2023 - Product Thumbnail Image

Gene Therapy-Competitive landscape, 2023

  • Report
  • May 2023
  • 450 Pages
  • Global
From
RNA Interference Therapy-Competitive landscape, 2023 - Product Thumbnail Image

RNA Interference Therapy-Competitive landscape, 2023

  • Report
  • May 2023
  • 220 Pages
  • Global
From
From
RNA - Competitive Landscape, 2022 - Product Thumbnail Image

RNA - Competitive Landscape, 2022

  • Report
  • October 2022
  • 200 Pages
  • Global
From
From
From
From
Gene therapy in rare diseases - Epidemiology Forecast - 2032 - Product Thumbnail Image

Gene therapy in rare diseases - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
Rheumatoid Arthritis Drugs Market 2024-2028 - Product Thumbnail Image

Rheumatoid Arthritis Drugs Market 2024-2028

  • Report
  • October 2023
  • 162 Pages
  • Global
From
Loading Indicator

Gene therapy is a form of genomics that involves the introduction of genetic material into a patient's cells to treat or prevent a disease. It is a rapidly growing field of medicine, with the potential to revolutionize the treatment of genetic diseases. Gene therapy works by introducing a healthy gene into a patient's cells, replacing a defective gene or providing a missing gene. This can be done through a variety of methods, such as viral vectors, gene editing, and stem cell therapy. Gene therapy has the potential to provide long-term, curative treatments for a wide range of genetic diseases, including cancer, cystic fibrosis, and hemophilia. It is also being explored as a potential treatment for other conditions, such as Alzheimer's disease and Parkinson's disease. Gene therapy is a rapidly growing field, with many companies investing in research and development. Companies in the gene therapy market include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, and Spark Therapeutics. Show Less Read more